Advanced Cell Technology Inc (OTCBB - OTCQB:ACTC)
| 0.0748 Data as of May 17 |  -0.0002 / -0.27%Today’s Change | 0.05 Today|||52-Week Range 0.10 | +34.29% Year-to-Date |
Latest ACTC News | Press Releases
No recent news for Advanced Cell Technology Inc.
Today’s Trading
| Previous close | 0.08 |
| Today’s open | 0.08 |
| Day’s range | 0.07 - 0.08 |
| Volume | 18,744,336 |
| Average volume (3 months) | 6,813,507 |
| Market cap | $182.4M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +80.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -7.89% |
| P/E ratio | NM |
| Price/Sales | 249.15 |
| Price/Book | 17.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVIVInvivo Therapeutics ... | +0.02 | +0.70% |
| SLNCFSilence Therapeutics... | 0.00 | 0.00% |
| IMUCImmunoCellular Thera... | -0.01 | -0.39% |
| ONTYOncothyreon Inc | +0.02 | +1.02% |
Data as of 4:01pm ET, 05/17/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $466.5K |
| Annual profit (last year) | -$28.5M |
| Net profit margin | -6,115.12% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, Chief Executive & Financial Officer Gary H. Rabin |
Operations Director Rita Parker |
Corporate headquarters Marlborough, Massachusetts |
Forecasts
